跳至主要内容
临床试验/NCT02709356
NCT02709356已完成不适用

Proof of Concepts: Can a Supplement Ketogenic Based MCT Oil Increases Cerebral Capture Ketones in People With Alzheimer's Disease?

Université de Sherbrooke2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Quantification of brain glucose uptake

研究概览

简要总结

Evaluate and compare the changes in brain ketone and glucose uptake after taking two different MCT oil emulsions (60-40 oil or C8 oil) for one month, in a group of people with Alzheimer's disease and a control group.

详细描述

Based on a PET/MRI protocol, the aim of this study is to evaluate and compare the response to the dietary supplementation of two different MCT oils (60% C10 + 40% C8 or 100 % C8) in two groups, patients with Alzheimer's disease and healthy elderly people (N=10/group). After a baseline evaluation, participant will test one of the supplements during two successive periods of one month; each period of time ending with 18F-FDG and 11C-acetoacetate PET scans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Good general health for Control group
  • Diagnosis of Alzheimer's disease (NINCDS-ADRDA criteria) for AD group

排除标准

  • Depression
  • Medical or psychiatric conditions that could interfere with study participation
  • Fasting plasma glucose ≥7.0 mM (diabetes or prediabetes)
  • Already on MCT supplementation
  • Clinically-significant gastrointestinal disease/conditions
  • Clinically-significant liver disease/dysfunction
  • Clinically-significant renal disease/dysfunction
  • Clinically-significant cardiac disease/conditions
  • Hypertension
  • Uncontrolled dyslipidaemia
  • Vitamin B12 deficiency
  • Structured physical activity (more than 3 times/week)

研究组 & 干预措施

Alzheimer's disease

Experimental

Patients with mild Alzheimer's disease.

1-month of 60-40 MCT oil and 1-month of C8 MCT oil (order of the two intervention are randomized)

干预措施: 1-month of 60-40 MCT oil (Dietary Supplement)

Alzheimer's disease

Experimental

Patients with mild Alzheimer's disease.

1-month of 60-40 MCT oil and 1-month of C8 MCT oil (order of the two intervention are randomized)

干预措施: 1-month of C8 MCT oil (Dietary Supplement)

Controls

Experimental

Healthy elderly people

1-month of 60-40 MCT oil and 1-month of C8 MCT oil (order of the two intervention are randomized)

干预措施: 1-month of 60-40 MCT oil (Dietary Supplement)

Controls

Experimental

Healthy elderly people

1-month of 60-40 MCT oil and 1-month of C8 MCT oil (order of the two intervention are randomized)

干预措施: 1-month of C8 MCT oil (Dietary Supplement)

结局指标

主要结局

Quantification of brain glucose uptake

时间窗: 1-month

Brain glucose uptake (umol/100g/min) using 18-FDG PET scan

Quantification of brain acetoacetate uptake

时间窗: 1-month

Brain acetoacetate uptake (umol/100g/min) using 11C-AcAc PET scan

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验